Q3 2022 · 13F-HR
ACT CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2022-11-03 · accession 0001636587-22-000023
$72,457
Reported value
71
Positions
2022-09-30
Period end
The Brief · ACT CAPITAL MANAGEMENT, LLC · Q3 2022
AI · grounded in 13F
ACT CAPITAL MANAGEMENT, LLC established a new position in STAA valued at $15,719. The fund also initiated new stakes in XOM for $7,124 and DVN for $4,961. Additional new positions include KRYS, ARWR, and AXSM. The fund ended the period with 71 positions and total AUM of $72,457.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 852312305 | STAA | STAAR SURGICAL CO | $15,719 | 21.7% | 222,800 | Common | SOLE |
| 30231G102 | XOM | EXXON MOBIL CORP | $7,124 | 9.83% | 81,600 | Common | SOLE |
| 25179M103 | DVN | DEVON ENERGY CORP NEW | $4,961 | 6.85% | 82,500 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $4,064 | 5.61% | 58,300 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $3,652 | 5.04% | 110,500 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $3,257 | 4.50% | 73,000 | Common | SOLE |
| 166764100 | CVX | CHEVRON CORP NEW | $3,233 | 4.46% | 22,500 | Common | SOLE |
| 00486H105 | ADTN | ADTRAN HOLDINGS INC | $2,937 | 4.05% | 150,000 | Common | SOLE |
| 29415J106 | NVNO | ENVVENO MED CORP | $2,520 | 3.48% | 401,200 | Common | SOLE |
| 185063104 | CLSDUSD | CLEARSIDE BIOMEDICAL INC | $2,483 | 3.43% | 2,197,480 | Common | SOLE |
| 516806205 | 8LP1 | LAREDO PETROLEUM INC | $2,131 | 2.94% | 33,900 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $1,784 | 2.46% | 120,400 | Common | SOLE |
| 28249U105 | CLDNEUR | EIGER BIOPHARMACEUTICALS INC | $1,770 | 2.44% | 235,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA | $1,467 | 2.02% | 143,500 | Common | SOLE |
| 29273V100 | ET | ENERGY TRANSFER L P | $1,410 | 1.95% | 127,800 | Common | SOLE |
| 25278X109 | FANG | DIAMONDBACK ENERGY INC | $1,265 | 1.75% | 10,500 | Common | SOLE |
| G637AM102 | MYOVEUR | MYOVANT SCIENCES LTD | $1,078 | 1.49% | 60,000 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $937 | 1.29% | 151,100 | Common | SOLE |
| 45719W106 | IKT | INHIBIKASE THERAPEUTICS INC | $853 | 1.18% | 937,500 | Common | SOLE |
| 77543R102 | ROKU | ROKU INC | $761 | 1.05% | 13,500 | Common | SOLE |
| N01045108 | — | AFFIMED N V | $636 | 0.88% | 308,800 | Common | SOLE |
| G17766109 | CMBMF | CAMBIUM NETWORKS CORPORATION | $582 | 0.80% | 34,400 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $522 | 0.72% | 12,500 | Common | SOLE |
| M85548101 | SSYS | STRATASYS LTD | $504 | 0.70% | 35,000 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $469 | 0.65% | 62,500 | Common | SOLE |
| 44934S206 | ICADUSD | ICAD INC | $431 | 0.59% | 205,000 | Common | SOLE |
| 91332U101 | U | UNITY SOFTWARE INC | $398 | 0.55% | 12,500 | Common | SOLE |
| 92837L109 | VIST | VISTA OIL &GAS SAB DE CV SPON ADS EACH REP 1 ORD SHS SER A | $391 | 0.54% | 41,500 | Common | SOLE |
| 24790A101 | DENUSD | DENBURY INC COM | $345 | 0.48% | 4,000 | Common | SOLE |
| 98956A105 | ZETA | ZETA GLOBAL HOLDINGS CORP | $340 | 0.47% | 51,500 | Common | SOLE |
| 852234103 | XYZ | BLOCK INC | $330 | 0.46% | 6,000 | Common | SOLE |
| 35953D104 | FUBOGBP | FUBOTV INC | $284 | 0.39% | 80,000 | Common | SOLE |
| 74760R303 | — | QUALTEK SERVICES INC | $278 | 0.38% | 138,500 | Common | SOLE |
| 68235C107 | — | ONCOCYTE CORPORATION | $241 | 0.33% | 330,000 | Common | SOLE |
| 165167735 | EXE | CHESAPEAKE ENERGY CORP | $236 | 0.33% | 2,500 | Common | SOLE |
| 78137L105 | RUM | RUMBLE INC | $234 | 0.32% | 19,100 | Common | SOLE |
| 52187K101 | CYPH | LEAP THERAPEUTICS INC | $233 | 0.32% | 265,000 | Common | SOLE |
| 68236P107 | GTXIEUR | ONCTERNAL THERAPEUTICS INC | $187 | 0.26% | 210,000 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $186 | 0.26% | 120,600 | Common | SOLE |
| 86877M209 | SURFUSD | SURFACE ONCOLOGY INC | $177 | 0.24% | 170,500 | Common | SOLE |
| 833445109 | SNOW | SNOWFLAKE INC | $170 | 0.23% | 1,000 | Common | SOLE |
| 04537Y109 | — | ASPIRA WOMENS HEALTH INC | $155 | 0.21% | 417,123 | Common | SOLE |
| 25402D102 | DOCN | DIGITALOCEAN HLDGS INC | $145 | 0.20% | 4,000 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $142 | 0.20% | 3,400 | Common | SOLE |
| 57055L107 | MRKR | MARKER THERAPEUTICS INC | $131 | 0.18% | 354,400 | Common | SOLE |
| 64049K104 | — | NEOLEUKIN THERAPEUTICS INC | $127 | 0.18% | 199,000 | Common | SOLE |
| 58490H107 | MDNAF | MEDICENNA THERAPEUTICS CORP | $124 | 0.17% | 149,070 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $122 | 0.17% | 47,500 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $97 | 0.13% | 90,000 | Common | SOLE |
| 26142Q205 | DPRO | DRAGANFLY INC | $95 | 0.13% | 135,000 | Common | SOLE |
| 12482W200 | YCBD | CBDMD INC | $77 | 0.11% | 22,000 | Common | SOLE |
| 15117F807 | CLRBUSD | CELLECTAR BIOSCIENCES INC | $73 | 0.10% | 21,750 | Common | SOLE |
| M4130Y106 | ENLV | ENLIVEX THERAPEUTICS LTD | $64 | 0.09% | 15,000 | Common | SOLE |
| 868153107 | SDPIUSD | SUPERIOR DRILLING PRODS INC | $54 | 0.07% | 80,000 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $48 | 0.07% | 28,500 | Common | SOLE |
| 23283X206 | CTSO | CYTOSORBENTS CORP | $48 | 0.07% | 35,000 | Common | SOLE |
| 69242L106 | OYST | OYSTER PT PHARMA INC | $48 | 0.07% | 8,500 | Common | SOLE |
| 98459U103 | YALA | YALLA GROUP LTD | $44 | 0.06% | 13,500 | Common | SOLE |
| 829399104 | AXONEUR | SIO GENE THERAPIES INC | $41 | 0.06% | 146,500 | Common | SOLE |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $36 | 0.05% | 12,000 | Common | SOLE |
| 78472W104 | SQZB | SQZ BIOTECHNOLOGIES CO | $36 | 0.05% | 16,000 | Common | SOLE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $29 | 0.04% | 15,000 | Common | SOLE |
| 12482W101 | YCBD | CBDMD INC | $28 | 0.04% | 125,000 | Common | SOLE |
| 09071M205 | — | BIOLINE RX LTD | $25 | 0.03% | 27,500 | Common | SOLE |
| 45783C101 | TIL | INSTIL BIO INC | $24 | 0.03% | 5,000 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $23 | 0.03% | 3,499 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $15 | 0.02% | 18,777 | Common | SOLE |
| 009496100 | AIRS | AIRSCULPT TECHNOLOGIES INC | $10 | 0.01% | 1,500 | Common | SOLE |
| 89357L105 | RNAZ | TRANSCODE THERAPEUTICS INC | $7 | 0.01% | 6,500 | Common | SOLE |
| 37186H100 | — | GENETRON HOLDINGS LIMITED | $6 | 0.01% | 7,500 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $3 | 0.00% | 900 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.